Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acu...
Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Paclitaxel-associated acute pain syndrome (P-APS) affects 80% of patients undergoing therapy. Although it has been shown that prednisone administration for 5 days relieves P-APS, detailed results have not been reported thus far. Therefore, in this study, we evaluated the preventive effect of dexamethasone (DEX) administration against P-A...
Alternative Titles
Full title
Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2212987027
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2212987027
Other Identifiers
ISSN
0941-4355
E-ISSN
1433-7339
DOI
10.1007/s00520-019-04808-y
